High-dose, but not low-dose, aspirin impairs anticontractile effect of ticagrelor following ADP stimulation in rat tail artery smooth muscle cells

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Grześk, Grzegorz ^a   Kozinski, Marek ^a   Tantry, Udaya S ^b   Wicinski, Michal ^a   Fabiszak, Tomasz ^a   Navarese, Eliano P ^a   Grzesk, Elzbieta ^a   Jeong, Young Hoon ^c   Gurbel, Paul A ^b   Kubica, Jacek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

^c Gyeongsang National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; PHENYLEPHRINE; TICAGRELOR; ADENOSINE; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; STIMULATION; TAIL ARTERY; VASOCONSTRICTION; ANIMAL; ARTERY; CYTOLOGY; MALE; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; TAIL; VASCULAR ENDOTHELIUM; ANALOGS AND DERIVATIVES; DRUG EFFECTS;

RATTUS; RATTUS NORVEGICUS;

ADENOSINE; ADENOSINE DIPHOSPHATE; ANIMALS; ARTERIES; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MALE; MUSCLE CONTRACTION; MYOCYTES, SMOOTH MUSCLE; RATS; TAIL; VASOCONSTRICTION;

EID: 84879376704     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/928271     Document Type: Article

References (42)

1. Wiviott S. D., Braunwald E., McCabe C. H., Montalescot G., Ruzyllo W., Gottlieb S., Neumann F., Ardissino D., De Servi S., Murphy S. A., Riesmeyer J., Weerakkody G., Gibson C. M., Antman E. M., Prasugrel versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine 2007 357 20 2001 2015 2-s2.0-36148983750 10.1056/NEJMoa0706482 (Pubitemid 350106708)
2. Wallentin L., Becker R. C., Budaj A., Cannon C. P., Emanuelsson H., Held C., Horrow J., Husted S., James S., Katus H., Mahaffey K. W., Scirica B. M., Skene A., Steg P. G., Storey R. F., Harrington R. A., Ticagrelor versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine 2009 361 11 1045 1057 2-s2.0-70149101223 10.1056/NEJMoa0904327
3. Navarese E. P., Verdoia M., Schaffer A., Surian P., Kozinski M., Castriota F., de Servi S., Kubica J., de Luca G., Ischaemic and bleeding complications with new, compared to standard, ADP-antagonist regimens in acute coronary syndromes: a meta-analysis of randomized trials. QJM 2011 104 7 561 569 2-s2.0-79959384296 10.1093/qjmed/hcr069 hcr069
4. Navarese E. P., Buffon A., Kozinski M., Obonska K., Rychter M., Kunadian V., Austin D., De Servi S., Sukiennik A., Kubica J., A critical overview on ticagrelor in acute coronary syndromes. Quarterly Journal of Medicine 2013 106 2 105 115 10.1093/qjmed/hcs187
5. Steg P. G., James S. K., Atar D., Badano L. P., Blömstrom-Lundqvist C., Borger M. A., Di Mario C., Dickstein K., Ducrocq G., Fernandez-Aviles F., Gershlick A. H., Giannuzzi P., Halvorsen S., Huber K., Juni P., Kastrati A., Knuuti J., Lenzen M. J., Mahaffey K. W., Valgimigli M., van't Hof A., Widimsky P., Zahger D., ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). European Heart Journal 2012 33 20 2569 2619 10.1093/eurheartj/ehs215
6. Jneid H., Anderson J. L., Wright R. S., Adams C. D., Bridges C. R., Casey D. E. Jr., Ettinger S. M., Fesmire F. M., Ganiats T. G., Lincoff A. M., Peterson E. D., Philippides G. J., Theroux P., Wenger N. K., Zidar J. P., Anderson J. L., 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Journal of the American College of Cardiology 2012 60 7 645 681 10.1161/CIR.0b013e318256f1e0
7. Gurbel P. A., Bliden K. P., Butler K., Tantry U. S., Gesheff T., Wei C., Teng R., Antonino M. J., Patil S. B., Karunakaran A., Kereiakes D. J., Parris C., Purdy D., Wilson V., Ledley G. S., Storey R. F., Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009 120 25 2577 2585 2-s2.0-73949112820 10.1161/CIRCULATIONAHA.109.912550
8. Serebruany V. L., Mortality benefit in PLATO cannot be explained by antiplatelet properties of ticagrelor. Cardiology 2011 117 3 231 233 2-s2.0-78650869896 10.1159/000322789
9. Wihlborg A., Wang L., Braun O. Ö., Eyjolfsson A., Gustafsson R., Gudbjartsson T., Erlinge D., ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 10 1810 1815 2-s2.0-5344257562 10.1161/01.ATV.0000142376.30582.ed (Pubitemid 39350296)
10. Grzesk G., Kozinski M., Navarese E. P., Krzyzanowski M., Grzesk E., Kubica A., Siller-Matula J. M., Castriota F., Kubica J., Ticagrelor, but not clopidogrel and prasugrel, prevents ADP-induced vascular smooth muscle cell contraction: a placebo-controlled study in rats. Thrombosis Research 2012 17 2 164 172 2-s2.0-84855877355 10.1016/j.thromres.2011.12.029
11. Högberg C., Svensson H., Gustafsson R., Eyjolfsson A., Erlinge D., The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature. International Journal of Cardiology 2010 142 2 187 192 2-s2.0-77953293012 10.1016/j.ijcard.2008.12.091
12. van Giezen J. J., Sidaway J., Glaves P., Kirk I., Björkman J. A., Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model. Journal of Cardiovascular Pharmacology Therapy 2012 17 2 164 172
13. Öhman J., Kudira R., Albinsson S., Olde B., Erlinge D., Ticagrelor induces adenosine triphosphate release from human red blood cells. Biochemical and Biophysical Research Communications 2012 418 4 754 758 2-s2.0-84857444798 10.1016/j.bbrc.2012.01.093
14. Mahaffey K. W., Wojdyla D. M., Carroll K., Becker R. C., Storey R. F., Angiolillo D. J., Held C., Cannon C. P., James S., Pieper K. S., Horrow J., Harrington R. A., Wallentinon L., Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation 2011 124 5 544 554 2-s2.0-80051550924 10.1161/CIRCULATIONAHA.111. 047498
15. AstraZeneca,. Brilinta REMS Document, NDA 22-433, 2011, http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm263964.htm
16. Guide for the care and use of laboratory animals. Office of Science and Health Reports 1985 (NIH) 85-23 Bethesdo, Md,USA DRR/NIH
17. Giachini F. R. C., Osmond D. A., Zhang S., Carneiro F. S., Lima V. V., Inscho E. W., Webb R. C., Tostes R. C., Clopidogrel, independent of the vascular P2Y12 receptor, improves arterial function in small mesenteric arteries from AngII-hypertensive rats. Clinical Science 2010 118 7 463 471 2-s2.0-74749100152 10.1042/CS20090392
18. van Rossum J. M., Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Archives Internationales de Pharmacodynamie et de Thérapie 1963 143 299 330 2-s2.0-73649209211
19. Pope J. E., Anderson J. J., Felson D. T., A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Archives of Internal Medicine 1993 153 4 477 484 2-s2.0-0027472279 10.1001/archinte.153.4.477 (Pubitemid 23064991)
20. Johnson A. G., Nguyen T. V., Day R. O., Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Annals of Internal Medicine 1994 121 4 289 300 2-s2.0-0028580588
21. Bautista L. E., Vera L. M., Antihypertensive effects of aspirin: what is the evidence? Current Hypertension Reports 2010 12 4 282 289 2-s2.0-77956267897 10.1007/s11906-010-0115-5
22. Hermida R. C., Ayala D. E., Calvo C., López J. E., Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients. Journal of the American College of Cardiology 2005 46 6 975 983 2-s2.0-23844526224 10.1016/j.jacc.2004.08.071 (Pubitemid 41316502)
23. Hermida R. C., Ayala D. E., Calvo C., López J. E., Mojón A., Rodríguez M., Fernández J. R., Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. Hypertension 2005 46 4 1060 1068 2-s2.0-33644644328
24. Leinonen V., Varis J., Vesalainen R., Päivärinta J., Sillanpää M., Kantola I., Low-dose acetylsalicylic acid and blood pressure control in drug-treated hypertensive patients. European Journal of Cardiovascular Prevention and Rehabilitation 2011 18 1 136 140 2-s2.0-79959252860 10.1097/HJR.0b013e32833ace3a
25. Avanzini F., Palumbo G., Alli C., Roncaglioni M. C., Ronchi E., Cristofari M., Capra A., Rossi S., Nosotti L., Costantini C., Pietrofeso R., Effects of low-dose aspirin on clinic and ambulatory blood pressure in treated hypertensive patients. American Journal of Hypertension 2000 13 6 611 616 2-s2.0-0033911534 10.1016/S0895-7061(00)00231-4 (Pubitemid 30461781)
26. Zanchetti A., Hansson L., Leonetti G., Rahn K., Ruilope L., Warnold I., Wedel H., Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy. Journal of Hypertension 2002 20 5 1015 1022 2-s2.0-0036562978 10.1097/00004872-200205000-00038 (Pubitemid 34913684)
27. Nawarskas J. J., Townsend R. R., Cirigliano M. D., Spinler S. A., Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan. American Journal of Hypertension 1999 12 8 I 784 789 2-s2.0-0032835496 10.1016/S0895-7061(99)00037-0 (Pubitemid 29416793)
28. Warner T. D., Nylander S., Whatling C., Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy. British Journal of Clinical Pharmacology 2011 72 4 619 633 2-s2.0-80052611377 10.1111/j.1365-2125.2011.03943.x
29. Aldasoro M., Mauricio M. D., Serna E., Cortina B., Medina P., Segarra G., Novella S., Vila J. M., Aspirin and COX-2inhibitor nimesulide potentiate adrenergic contractions of human gastroepiploic artery. American Journal of Hypertension 2007 20 5 514 519 2-s2.0-34247555922 10.1016/j.amjhyper.2006.12.002 (Pubitemid 46678708)
30. Aldasoro M., Mauricio M. D., Serna E., Cortina B., Segarra G., Medina P., Vila J. M., Flor B., Lluch S., Effects of aspirin, nimesulide, and SC-560 on vasopressin-induced contraction of human gastroepiploic artery and saphenous vein. Critical Care Medicine 2008 36 1 193 197 2-s2.0-37549006772 10.1097/01.CCM.0000292155.06797.62
31. Taubert D., Berkels R., Grosser N., Schröder H., Gründemann D., Schömig E., Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. British Journal of Pharmacology 2004 143 1 159 165 2-s2.0-4644354462 10.1038/sj.bjp.0705907 (Pubitemid 39280035)
32. Ying Z., Giachini F. R. C., Tostes R. C., Webb R. C., Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation. Cardiovascular Research 2009 83 1 155 162 2-s2.0-67649369545 10.1093/cvr/cvp084
33. FitzGerald G. A., Oates J. A., Hawiger J., Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. Journal of Clinical Investigation 1983 71 3 676 688 2-s2.0-0020692577 (Pubitemid 13160815)
34. Weksler B. B., Pett S. B., Alonso D., Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. The New England Journal of Medicine 1983 308 14 800 805 2-s2.0-0020537396 (Pubitemid 13114674)
35. Davi G., Custro N., Novo S., The effect of two low doses of aspirin on whole blood thromboxane and prostacyclin generation in healthy subjects. Thrombosis and Haemostasis 1983 50 3 669 670 2-s2.0-0021065859 (Pubitemid 14245956)
36. Duffy S. J., Castle S. F., Harper R. W., Meredith I. T., Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. Circulation 1999 100 19 1951 1957 2-s2.0-0033539618 (Pubitemid 29529286)
37. Friedman P. L., Brown E. J. Jr., Gunther S., Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. The New England Journal of Medicine 1981 305 20 1171 1175 2-s2.0-0019824012 (Pubitemid 12237475)
38. Rudic R. D., Brinster D., Cheng Y., Fries S., Song W., Austin S., Coffman T. M., FitzGerald G. A., COX-2-derived prostacyclin modulates vascular remodeling. Circulation Research 2005 96 12 1240 1247 2-s2.0-21844451360 10.1161/01.RES.0000170888.11669.28 (Pubitemid 40962101)
39. Egan K. M., Wang M., Fries S., Lucitt M. B., Zukas A. M., Puré E., Lawson J. A., FitzGerald G. A., Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation 2005 111 3 334 342 (Pubitemid 40165341)
40. Armstrong P. C. J., Leadbeater P. D., Chan M. V., Kirkby N. S., Jakubowski J. A., Mitchell J. A., Warner T. D., In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation. Journal of Thrombosis and Haemostasis 2011 9 3 552 561 2-s2.0-79952045828 10.1111/j.1538-7836.2010.04160.x
41. Kirkby N. S., Leadbeater P. D. M., Chan M. V., Nylander S., Mitchell J. A., Warner T. D., Antiplatelet effects of aspirin vary with level of P2Y12 receptor blockade supplied by either ticagrelor or prasugrel. Journal of Thrombosis and Haemostasis 2011 9 10 2103 2105 2-s2.0-80053399937 10.1111/j.1538-7836.2011.04453.x
42. Bhavaraju K., Georgakis A., Jin J., Kent Gartner T., Tomiyama Y., Nurden A., Nurden P., Kunapuli S. P., Antagonism of P2Y12 reduces physiological thromboxane levels. Platelets 2010 21 8 604 609 2-s2.0-78149454375 10.3109/09537104.2010.511684